Identification of EEF1A1 as a therapeutic target in TNBC: Anticancer action of a novel Penicillide-derived inhibitor through ribosomal protein regulation

Key Points

• EEF1A1 shows promise as a therapeutic target for anticancer action in TNBC.
• The novel penicillide-derived inhibitor impacts ribosomal protein regulation effectively.
• Analysis uncovered a significant link between EEF1A1 inhibition and tumor suppression.
• Research highlights the potential of targeting EEF1A1 as a new strategy against TNBC.